Asia Pacific Continuous Glucose Monitoring Systems Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Asia Pacific Continuous Glucose Monitoring (CGM) Market Size & Share by Company and it is Segmented by individual components such as sensors and durables (receivers and transmitters) and Geography. The market provides the value (in USD million) and volume (in Units million) for the above segments.

Asia Pacific Continuous Glucose Monitoring Systems Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Asia Pacific Continuous Glucose Monitoring (CGM) Market Size

View Global Report
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 11.74 %

Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Asia-Pacific Continuous Glucose Monitoring Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Asia Pacific Continuous Glucose Monitoring (CGM) Market Analysis

The Asia-Pacific Continuous Glucose Monitoring Market is expected to register a CAGR of 11.74% during the forecast period.

The COVID-19 pandemic positively impacted the Asia-Pacific Diabetes Care Devices Market growth. Patients with diabetes, infected with COVID-19 may experience elevated blood glucose, abnormal glucose variability, and diabetic complications. The prevalence of diabetes in people with COVID-19 caused a significant increase in severity and mortality of COVID-19 in people with either type 1 (T1DM) or type 2 diabetes mellitus (T2DM), especially in association with poor glycemic control. While new-onset hyperglycemia and new-onset diabetes (both T1DM and T2DM) have been increasingly recognized in the context of COVID-19 and have been associated with worse outcomes. To avoid aggravation, a patient's blood glucose should be monitored regularly, which has underlined the importance of blood glucose monitoring devices. The pandemic emergency has created a rise in remote care from both patients and providers and removed many long-standing regulatory barriers.

According to International Diabetes Federation (IDF), 90 million adults (20-79) are living with diabetes in the IDF South-East Asia (SEA) Region in 2021. This figure is estimated to increase to 152 million by 2045 and 206 million adults (20-79) are living with diabetes in the IDF Western Pacific Region in 2021 which is estimated to increase to 260 million by 2045. The main diagnosis for diabetes patients is imbalances in blood glucose levels, which are not in compliance with the standard blood glucose levels. The general lab diagnostic tests can only help to diagnose the disease by physicians. Patients with more fluctuations in glucose levels need to get it checked every day. Patients administering insulin need to check their blood glucose levels frequently, adjust the doses of insulin, or change the medication, if necessary.

The incidence of newly diagnosed cases of Type 1 and Type 2 diabetes is observed to be on the rise, primarily attributed to factors such as obesity, unhealthy dietary habits, and lack of physical activity. The escalating frequency and pervasiveness of diabetic patients and healthcare expenses in developed nations are indicative of the growing utilization of diabetic care products. Furthermore, the mounting adoption of insulin delivery devices and the surging prevalence of diabetes are propelling the expansion of the market. Prominent manufacturers are directing their efforts towards technological advancements and the creation of sophisticated products to secure a significant market share.

Asia Pacific Continuous Glucose Monitoring (CGM) Industry Overview

A significant share of the Asia-Pacific Continuous Glucose Monitoring Devices market study is held by CGM manufacturers concurrently with strategy-based M&A operations. These manufacturers continuously enter new markets to generate new revenue streams and boost existing ones. The market studied is consolidated with Dexcom, Abbott, and Medtronic, holding a high market share, followed by regional manufacturers accounting for a relatively smaller share.

Asia Pacific Continuous Glucose Monitoring (CGM) Market Leaders

  1. Dexcom

  2. Medtronic

  3. Abbott

  4. Senseonics

  5. Ascensia

  6. *Disclaimer: Major Players sorted in no particular order
Asia-Pacific Continuous Glucose Monitoring Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Asia Pacific Continuous Glucose Monitoring (CGM) Market News

  • March 2022: Abbott announced that it received expanded reimbursement coverage in Japan for the FreeStyle Libre system. Japan's Ministry of Health, Labor, and Welfare approved the expansion of the continuous glucose monitoring (CGM) system to include all people with diabetes who use insulin at least once per day.
  • July 2021: Dexcom and Terumo Corporation signed an agreement for exclusively distributing Dexcom G6 across Japan.

Asia Pacific Continuous Glucose Monitoring (CGM) Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Component
    • 5.1.1 Sensors
    • 5.1.2 Durables
  • 5.2 Geography
    • 5.2.1 Australia
    • 5.2.2 China
    • 5.2.3 India
    • 5.2.4 Indonesia
    • 5.2.5 Japan
    • 5.2.6 Malaysia
    • 5.2.7 Philippines
    • 5.2.8 South Korea
    • 5.2.9 Thailand
    • 5.2.10 Vietnam
    • 5.2.11 Rest of Asia-Pacific

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Abbott
    • 7.1.2 Dexcom
    • 7.1.3 Medtronics
    • 7.1.4 Eversense
    • 7.1.5 Ascensia
  • *List Not Exhaustive
  • 7.2 Company Share Analysis

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Asia Pacific Continuous Glucose Monitoring (CGM) Industry Segmentation

Blood sugar levels are automatically monitored by continuous glucose monitoring both throughout the day and at night. Patients with diabetes can quickly and easily see their glucose level anytime. Patients can also review the glucose fluctuations over a few hours or days to spot trends. Real-time glucose monitoring enables patients to manage their diet, physical activity, and medications more intelligently throughout the day. The Asia Pacific Continuous Glucose Monitoring Market is segmented by Component (Sensors and Durables) and Geography. The report offers the value (in USD) and volume (in Units) for the above segments. We will provide a segment-wise breakdown (Value and Volume) for all the countries covered under the Table of Contents.

Component Sensors
Durables
Geography Australia
China
India
Indonesia
Japan
Malaysia
Philippines
South Korea
Thailand
Vietnam
Rest of Asia-Pacific
Need A Different Region or Segment?
Customize Now

Asia Pacific Continuous Glucose Monitoring (CGM) Market Research FAQs

What is the current Asia-Pacific Continuous Glucose Monitoring Market size?

The Asia-Pacific Continuous Glucose Monitoring Market is projected to register a CAGR of 11.74% during the forecast period (2025-2030)

Who are the key players in Asia-Pacific Continuous Glucose Monitoring Market?

Dexcom, Medtronic, Abbott, Senseonics and Ascensia are the major companies operating in the Asia-Pacific Continuous Glucose Monitoring Market.

What years does this Asia-Pacific Continuous Glucose Monitoring Market cover?

The report covers the Asia-Pacific Continuous Glucose Monitoring Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Asia-Pacific Continuous Glucose Monitoring Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Asia Pacific Continuous Glucose Monitoring Systems Industry Report

Statistics for the 2025 Asia-Pacific Continuous Glucose Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Continuous Glucose Monitoring analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.